Fig. 2: The primary and secondary outcomes. | npj Digital Medicine

Fig. 2: The primary and secondary outcomes.

From: Randomized clinical trial of a digital medication system to enhance adherence in patients with severe mental disorders

Fig. 2

This figure compares primary and secondary outcomes between the intervention and control groups across five visits: baseline, 1 month, 3 months, 6 months, and 12 months. a The primary outcome, self-reported medication adherence, is presented for each visit, with the intervention group represented by red bars and the control group by blue bars. b compares adherence rates between the groups based on the digital medication monitor. c and d show changes in the Medication Adherence Rating Scale (MARS) and Fatigue and Behavioral Symptoms (FBS) scores, respectively, over the 12-month period. The red dashed line represents the intervention group, while the blue solid line represents the control group. Significant differences between groups are indicated by asterisks (*). Error bars in (b), (c) and (d) indicate the standard error. MARS Medication Adherence Rating Scale, FBS Fatigue and Behavioral Symptoms.

Back to article page